Renacet 475 mg/Renacet 950 mg
Renacet 475 mg / Renacet 950 mg extracts phosphate from foods and expels it in one's stool. Used for chronic kidney failure with dialysis
Indication
Hyperphosphatemia during dialysis-related chronic renal failure (phosphate binding agent).
Product features
Among the three best cheapest compounds (aut idem)
Dosage 475 mg = 3 mmol/l950 mg = 6 mmol/l
(requires slightly more calcium compared to a 500 mg or 1000 mg compound)
Individually sealed and packaged
Lubricating film allows easy swallowing
950 mg tablets are scored for splitting easily
(individual dosages are easy to take)
Dosage
Take as prescribed by a personal doctor. Renacet 475 mg / Renacet 950 mg should be swallowed whole at mealtimes with minimal fluids.
Commercial data
| Name | PZN | Package Size | Order Number |
|---|---|---|---|
| Renacet 475 mg | 081759 2 | 100 film coated tablets | 2110-2 |
| Renacet 475 mg | 410337 5 | 200 film coated tablets | 2120-2 |
| Renacet 950 mg | 081756 3 | 100 film coated tablets | 2210-2 |
| Renacet 950 mg | 410338 1 | 200 film coated tablets | 2220-2 |
Mandatory Data
Name of the drug:
Renacet 475 mg; Renacet 950 mg (pharmacies only)
Active Substance:
Calciumacetat (anhydrous)
Marketing Authorisation Number:
Renacet 475 mg: 43745.00.00
Renacet 950 mg: 43745.01.00
For risks and side-effects read the package insert and ask your doctor or pharmacist.
Marketing Authorisation Holder:
RenaCare NephroMed GmbH
Werrastr. 1a
35625 Hüttenberg
Germany